COVID vaccine sees global markets soar
Published 10-NOV-2020 09:14 A.M.
3 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
The announcement that Pfizer and BioNTech’s COVID-19 vaccine was 90% effective in tests saw global markets soar overnight.
However, Nigel Green, the chief executive and founder of deVere Group believes global stock markets are “overthinking the positive vaccine news.
Londons’ FTSE 100 soared on Monday by 5.5% and Wall Street benchmark S&P 500 index closed at a two-month high amid strong trading volume.
Mr Green observes: “The news is fuelling hope that economies around the world can soon return to normal and this is driving global stock markets.
“The vaccine development reports are, obviously, an important step in the right direction.
“However, I suspect the markets – which are already in a bullish mood due to the incoming Biden administration – are overthinking the positive vaccine news.
“They are being premature in their buoyancy.
“There’s a long road ahead still. We will find out on the third week of November then as we wait to see if the vaccine can be approved or not.”
He cautions: “Stocks, including beleaguered travel sector stocks amongst others, are soaring on the back of the news.
“But I would urge investors to remain optimistically cautious and avoid the ‘buy everything’ mindset
“The world is still readjusting and many of the changes that have come about from the pandemic are unlikely to be reversed, including the workplace revolution in which more and more people are working from home.”
While stocks did climb, bonds tumbled, but volatility remains in the US with Donald Trump contesting the election result, and President elect Joe Biden set to implement stricter COVID policies.
Joshua Mahony, Senior Market Analyst at IG, discusses a Biden victory below.
“Another day of gains across global stocks comes as the dust settles on the US election. While coronavirus risks remain, the prospect of a less combative President helps global growth prospects.
“Meanwhile, the UK markets are being led by housing names after positive news from Taylor Wimpey and Countrywide. European markets are on the rise once again, with global stocks looking to carry on the bullish tone set throughout much of last week.
“Joe Biden may still have a host of law-suits from Trump to contend with, yet the risk-on sentiment we are seeing throughout markets highlights a confidence within the trading community that these legal challenges are nothing more than a bid to save face.
“Trump may hope that an extended legal challenge will push the decision into the hands of the Republican dominated supreme court, much like the 2000 election.
“However, while the Gore-Bush election was almost too-close-to-call, the 290-214 loss for Trump leaves little uncertainty over who has won this time around.
“Outside of the US, Biden’s victory is expected to mark a break from the combative approach of his predecessor, with trade relations likely to improve after years of tariffs and threats.
“Instead, we are seeing a risk-on surge across global markets, with the change in leadership expected to bring lower tariffs, and higher stimulus. However, Biden’s immediate decision to form a coronavirus taskforce does highlight the more pressing risk, with his leadership raising the likeliness of a nationwide lockdown as US cases top 10-million for the first time.”
S&P 500 +1.17%
FTSE 100 +4.67%
CAC 40 +7.57%
Asia Dow +1.06%
Nikkei 225 2.12%
Hang Seng 1.18%
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.